Wang Sheng
- Molecular Biology top 10%
- Biomedical Engineering top 10%
- Biomaterials top 2%
- Cancer Research top 5%
- Materials Chemistry
- Topics
- Nanoplatforms for cancer theranostics (13 papers)MicroRNA in disease regulation (9 papers)RNA Interference and Gene Delivery (7 papers)
- Partner nations
- ChinaRussiaUnited States
In The Last Decade
Wang Sheng
45 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 751
- Biomedical Engineering 465
- Biomaterials 455
- Cancer Research 369
- Materials Chemistry 178
Countries citing papers authored by Wang Sheng
This map shows the geographic impact of Wang Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Sheng more than expected).
Fields of papers citing papers by Wang Sheng
This network shows the impact of papers produced by Wang Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Sheng. The network helps show where Wang Sheng may publish in the future.
Co-authorship network of co-authors of Wang Sheng
This figure shows the co-authorship network connecting the top 25 collaborators of Wang Sheng. A scholar is included among the top collaborators of Wang Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Sheng. Wang Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 15 | |
| 5 | 2 | |
| 6 | 12 | |
| 7 | 17 | |
| 8 | 3 | |
| 9 | 15 | |
| 10 | 28 | |
| 11 | 26 | |
| 12 | 97 | |
| 13 | 125 | |
| 14 | 9 | |
| 15 | Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancerbreakdown → | 443 |
| 16 | 73 | |
| 17 | 74 | |
| 18 | 55 | |
| 19 | 47 | |
| 20 | Expression of Notch-related Genes in the Differentiation of Mesenchymal Progenitor Cell, Kusa-A1. | 1 |
About Wang Sheng
Wang Sheng is a scholar working on Structural Biology, Cancer Research and Biomaterials, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (13 papers), MicroRNA in disease regulation (9 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Biomaterials (455 citations), Cancer Research (369 citations) and Pharmaceutical Science (75 citations). Wang Sheng has collaborated with scholars based in China, Russia and United States. Frequent co-authors include Yan Wu, Xiongwei Deng, Zhixiang Zhou, Kelei Hu, Xiangqian Xiao, Yi Zeng, Minjun Cao, Yishu Yang, Zhaoxia Yin and Jiakun Zhang. Their work appears in journals such as PLoS ONE, Biomaterials and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.